摘要
随着生物技术的不断发展,循环肿瘤细胞(CTC)现象的普遍性和重要性在肿瘤临床实践中逐渐得到重视,现已成为乳腺癌患者生存时间和生存率的优秀评测指标之一,对临床化疗药物开发和肿瘤疫苗的发明也可以起到推动和加速作用。本文回顾了CTC现象的发现历史,检测技术的发展及其在乳腺癌的应用现状和前景。
出处
《中华医学杂志》
CAS
CSCD
北大核心
2010年第32期2291-2295,共5页
National Medical Journal of China
基金
基金项目:广东省科技计划基金(20078030703011)
广东省自然科学基金(815008004000014)
参考文献53
-
1Seronie-Vivien S,Mery E,Delord J,et al.Carcinocythemia as the single extension of breast cancer:report of a case and review of the literature.Ann Oncol,2001,12:1019-1022.
-
2Ashworth T.A case of cancer in which cells similar to those in the tumours were seen in the blood after death.Aust Med J,1969,14:146.
-
3Carey R,Taft P,Bennett J,et al.Carcinocythemia (carcinoma cell leukemia).An acute leukemia-like picture due to metastatic carcinoma cells.Am J Med,1976,60:273-278.
-
4Engell H.Cancer cells in the circulating blood:a clinical study on the occurrence of cancer cells in the peripheral blood and in venous blood draining the tumour area at operation.Ugeskr Laeger,1955,117:822-823.
-
5Roberts S,Watne A,McGrath R,et al.Technique and results of isolation of cancer cells from the circulating blood.AMA Arch Surg,1958,76:33,4-346.
-
6Guller U,Zajac P,Schnider A,et al.Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer.Ann Surg,2002,236:768-775.
-
7Pelkey T,Frierson H,Bruns D.Molecular and immunological detection of circulating tumor cells and micrometastases from solid tumors.Clin Chem,1996,42:1369-1381.
-
8Israeli R,Miller Jr W,Su S,et al.Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells:comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays.Cancer Res,1994,54:6306-6310.
-
9Ghossein R,Bhattacharya S,Rosai J.Molecular detection of micrometastases and circulating tumor cells in solid tumors.Clin Cancer Res,1999,5:1950-1960.
-
10Braun S,Pantel K,Muller P,et al.Cytokeratin-positive cells in the bone marrow and survival of patients with stage Ⅰ,Ⅱ,or Ⅲ breast cancer.N Engl J Med,2000,24:525-533.
同被引文献43
-
1Kim HJ, Park CI, Park BW, et al. Expression of MT-1 MMP, MMP2, MMP9 and TIMP2 mRNAs in ductal carcinoma in situ andinvasive ductal carcinoma of the breast. Yonsei Med J, 2006,47: 333-342.
-
2Badruddoja M. Micrometastasis and axillary dissection in breast cancer. Arch Surg,2010 ,145:1022-1023.
-
3Wu CY, Wu MS, Chen YJ, et al. Clinicopathological significance of MMP-2 and TIMP-2 genotypes in gastric cancer. Eur J Cancer, 2007,43:799-808.
-
4Bhuvarahamurthy V, Kristiansen GO, Johannsen M, et al. In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMI~, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma. Oncol Rep,2006,15:1379-138g.
-
5Kenny HA, Lengyel E. MMP-2 functions as an early response protein in ovarian cancer metastasis. Cell Cycle ,2009,8:683-688.
-
6Leppa S, Saarto T, Vehmanen L, et al. A high serum matrix metalloproteinase-2 level is associated with an adverse prognosis in node-positive breast carcinoma. Clin Cancer Res,2004,10 : 1057- 1063.
-
7Chen Y, Zou TN, Wu ZP, et al. Detection of cytokeratin 19, human mammaglobin, and carcinoembryonic antigen-positive circulating tumor cells by three-marker reverse transcription-PCR assay and its relation to clinical outcome in early breast cancer. Int J Biol Markers,2010,25:59-68.
-
8ASWORTH T R. A case of cancer in which cells similar to those in tumors were seen in the blood after death [J]. Aust Med J, 1869, 14: 146- 149.
-
9LIU M C, SHIELDS P G, WARREN R D, et al. Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer [J]. J Clin Oncol, 2009, 27(31): 5153-5159.
-
10JEMAL A, BRAY F, CENTER M M, et al. Glohal cancer statistics [J]. CA Cancer J Clin, 201 1, 61 (2): 69-90.
引证文献2
-
1张聚良,姚青,陈江浩,王廷,王辉,樊菁,王岭.早期乳腺癌血清MMP-2水平与外周血循环肿瘤细胞的相关性及临床意义[J].中华医学杂志,2012,92(16):1104-1106. 被引量:4
-
2李蕾,江泽飞.循环肿瘤细胞检测在不同阶段不同类型乳腺癌中的应用[J].中国癌症杂志,2013,23(8):570-575. 被引量:21
二级引证文献25
-
1夏莉莉,黄华艺.血清可溶性基质金属蛋白酶与肿瘤关系的研究进展[J].中国临床新医学,2014,7(5):469-474. 被引量:3
-
2李蕾,刘毅,张少华,王涛,边莉,吴世凯,宋三泰,刘兵,江泽飞.循环肿瘤细胞检测在不同阶段不同类型乳腺癌中的应用及意义[J].中华医学杂志,2014,94(36):2812-2815. 被引量:13
-
3陈卓,许新华.循环肿瘤细胞分子特性研究进展[J].实用医学杂志,2015,31(5):852-854. 被引量:4
-
4齐帆,边莉,张少华,王涛,王炎,宋三泰,江泽飞.扩增子测序技术应用于乳腺癌循环游离DNA无创性检测的研究[J].生物技术通讯,2015,26(3):389-392. 被引量:1
-
5陈卓,许新华.循环肿瘤细胞侵袭转移的研究进展[J].广东医学,2015,36(13):2112-2114. 被引量:7
-
6解继平,张岷,方红,赵子伟,万毅,姚永强.循环肿瘤细胞检测在不同转移灶晚期乳腺癌中的应用研究[J].大连医科大学学报,2015,37(5):493-495. 被引量:4
-
7王丽娟,张研,吕昭宝.乳腺癌循环肿瘤细胞与分子生物学特征的相关性分析[J].中国实验诊断学,2015,19(11):1946-1950. 被引量:9
-
8罗菊锐,俞晓立.循环肿瘤细胞检测对乳腺癌预后与治疗的意义[J].中华放射肿瘤学杂志,2016,25(4):420-424. 被引量:3
-
9孙凤荣,马德亮,张佃富,苏庆光.早期乳腺癌患者手术对循环肿瘤细胞的影响[J].中国肿瘤临床与康复,2016,23(11):1284-1286. 被引量:3
-
10滕娟,路玉英.免疫磁微球在肿瘤细胞中的提取应用[J].中国医学创新,2016,13(36):129-132.
-
1何声秀,吕丽荣.转移性乳腺癌化疗进展[J].现代诊断与治疗,2002,13(3):155-158. 被引量:5
-
2孙立,乌日娜.端粒—端粒酶与皮肤病[J].内蒙古医学杂志,2005,37(1):28-31.
-
3肖华,何永生.极光激酶B抑制剂与胶质瘤治疗的研究进展[J].实用医院临床杂志,2016,13(3):152-155. 被引量:1
-
4蔡三军,蔡国响.大肠癌的表遗传学研究[J].肿瘤研究与临床,2005,17(5):289-293.
-
5李南云,金行藻,印洪林,黄进,郑晓刚,张泰和,史勤.幽门螺杆菌与胃癌及胃异型增生[J].江苏医药,1994,20(7):350-352. 被引量:5
-
6张宏宇,张才全.放射免疫导向手术在大肠癌治疗中应用的研究进展[J].中国肛肠病杂志,2004,24(12):33-35.
-
7李伟.肿瘤微血管密度的研究进展[J].实用肿瘤学杂志,1999,13(2):159-160. 被引量:2
-
8赵嫄,胡婉丽,张连生.嵌合抗原受体疗法在血液肿瘤免疫治疗中的研究进展与应用前景[J].中华临床医师杂志(电子版),2014,8(6):134-137. 被引量:7
-
9本刊编辑部.作者须知[J].肿瘤研究与临床,2007,19(12):864-864.
-
10科研·动态[J].中国卫生人才,2005(10):5-5.